Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASARFI HOSPITAL LTD.

NSE : NABSE : 543943ISIN CODE : INE0DN001027Industry : Hospital & Healthcare ServicesHouse : Private

BSE199.501.6 (+0.81 %)

PREV CLOSE ( ) 197.90

OPEN PRICE ( ) 200.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7000

TODAY'S LOW / HIGH ( )196.00 200.50

52 WK LOW / HIGH ( ) 72.9221

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2025

Mar 2024

Operational & Financial Ratios

Earnings Per Share (Rs)

5.37

2.11

CEPS(Rs)

11.82

6.58

DPS(Rs)

0.00

Book NAV/Share(Rs)

41.16

35.78

Tax Rate(%)

26.10

33.32

Margin Ratios

Core EBITDA Margin(%)

19.53

19.03

EBIT Margin(%)

15.25

10.60

Pre Tax Margin(%)

11.87

7.39

PAT Margin (%)

8.77

4.93

Cash Profit Margin (%)

19.29

15.34

Performance Ratios

ROA(%)

6.65

2.70

ROE(%)

13.97

5.91

ROCE(%)

15.86

8.75

Asset Turnover(x)

0.76

0.55

Sales/Fixed Asset(x)

0.91

0.68

Working Capital/Sales(x)

6.91

67.51

Efficiency Ratios

Fixed Capital/Sales(x)

1.10

1.46

Receivable days

96.96

104.90

Inventory Days

6.17

7.78

Payable days

248.23

446.49

Valuation Parameters

PER(x)

15.43

30.89

PCE(x)

7.02

9.93

Price/Book(x)

2.01

1.83

Yield(%)

0.00

EV/Net Sales(x)

1.74

1.89

EV/Core EBITDA(x)

6.77

9.01

EV/EBIT(x)

11.43

17.87

EV/CE(x)

1.62

1.56

M Cap / Sales

1.35

1.52

Growth Ratio

Net Sales Growth(%)

42.85

0.00

Core EBITDA Growth(%)

75.17

0.00

EBIT Growth(%)

105.54

0.00

PAT Growth(%)

154.14

0.00

EPS Growth(%)

154.14

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.60

0.45

Current Ratio(x)

1.43

1.03

Quick Ratio(x)

1.37

0.99

Interest Cover(x)

4.51

3.31

Total Debt/Mcap(x)

0.30

0.25